RecruitingNot ApplicableNCT06414083

Histologic Comparison of Ablative Techniques for Endometriosis

Histologic Comparison of Ablative Techniques for Endometriosis - a Randomized Trial


Sponsor

TriHealth Inc.

Enrollment

141 participants

Start Date

May 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • Adult women 18 years of age or older
  • Already planning to undergo scheduled robotic assisted or laparoscopic excision of lesions for pelvic pain symptoms (pelvic pain, dysmenorrhea, dyspareunia, dysuria, dyschezia, ovarian pain) or endometriosis of any kind (endometriosis of any location, or endometrioma)

Exclusion Criteria1

  • Known pregnancy at enrollment or at the time of the excision surgery

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEDiathermy

Diathermy will be used to ablate the randomized sample.

DEVICECO2 Laser

CO2 Laser will be used to ablate the randomized sample.

DEVICEArgon Beam Coagulator

Argon Beam Coagulator will be used to ablate the randomized sample.


Locations(1)

Good Samaritan Hospital

Cincinnati, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06414083


Related Trials